LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Complications Common After Ankle Replacement
Large Joints and Extremities

Complications Common After Ankle Replacement

August 1, 2013 1 min read Premium comments

Advertisement

Complications Common After Ankle Replacement
Videofluoroscopy Ankle Replacement / Source: Wikimedia Commons and FA RenLis
Secondary

Thromboembolic complications and deep vein thrombosis are as common in patients who have total ankle replacements as they are in those who undergo hip or knee replacement. That is the result of a study presented at the American Orthopaedic Foot and Ankle Society Annual Meeting.

“The incidence of thromboembolic complications after total ankle replacement is between 0 and almost 10%, ” said Alexej Barg, M.D., study author. “In our patient cohort, the incidence was almost 3.5%, which is comparable to data observed in patients undergoing the replacement of a hip or knee joint.”

Barg and the researchers at Kantonsspital Liestal in Switzerland conducted a systematic review of the literature and extracted information on 964 total ankle replacements performed between 2000 and 2009 at 28 different clinics. The majority of studies included were level IV. Barg said there is limited literature on the incidence of thromboembolic prophylaxis after total ankle replacement (TAR).

They found a range of 0% to 10% of patients had thromboembolic complications after TAR and 3.5% of patients had symptomatic deep vein thrombosis following TAR. Twenty of 28 studies described low molecular weight heparin as the method of prophylaxis given to patients for six weeks postoperatively. “We suggest prophylaxis using low molecular weight heparin in patients with known risk factors, ” Barg said.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy